Literature DB >> 20683905

Association of folate receptor (FOLR1, FOLR2, FOLR3) and reduced folate carrier (SLC19A1) genes with meningomyelocele.

Michelle R O'Byrne1, Kit Sing Au, Alanna C Morrison, Jone-Ing Lin, Jack M Fletcher, Kathryn K Ostermaier, Gayle H Tyerman, Sabine Doebel, Hope Northrup.   

Abstract

BACKGROUND: Meningomyelocele (MM) results from lack of closure of the neural tube during embryologic development. Periconceptional folic acid supplementation is a modifier of MM risk in humans, leading toan interest in the folate transport genes as potential candidates for association to MM.
METHODS: This study used the SNPlex Genotyping (ABI, Foster City, CA) platform to genotype 20 single polymorphic variants across the folate receptor genes (FOLR1, FOLR2, FOLR3) and the folate carrier gene (SLC19A1) to assess their association to MM. The study population included 329 trio and 281 duo families. Only cases with MM were included. Genetic association was assessed using the transmission disequilibrium test in PLINK.
RESULTS: A variant in the FOLR2 gene (rs13908), three linked variants in the FOLR3 gene (rs7925545, rs7926875, rs7926987), and two variants in the SLC19A1 gene (rs1888530 and rs3788200) were statistically significant for association to MM in our population.
CONCLUSION: This study involved the analyses of selected single nucleotide polymorphisms across the folate receptor genes and the folate carrier gene in a large population sample. It provided evidence that the rare alleles of specific single nucleotide polymorphisms within these genes appear to be statistically significant for association to MM in the patient population that was tested.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683905      PMCID: PMC3046546          DOI: 10.1002/bdra.20706

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  37 in total

1.  Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.

Authors:  Laura J Williams; Cara T Mai; Larry D Edmonds; Gary M Shaw; Russell S Kirby; Charlotte A Hobbs; Lowell E Sever; Lisa A Miller; F John Meaney; Miriam Levitt
Journal:  Teratology       Date:  2002-07

Review 2.  Neural-tube defects.

Authors:  L D Botto; C A Moore; M J Khoury; J D Erickson
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

3.  Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol.

Authors:  S W Lacey; J M Sanders; K G Rothberg; R G Anderson; B A Kamen
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  Reduced folate carrier polymorphism (80A-->G) and neural tube defects.

Authors:  Patrizia De Marco; Maria Grazia Calevo; Anna Moroni; Elisa Merello; Alessandro Raso; Richard H Finnell; Huiping Zhu; Luciano Andreussi; Armando Cama; Valeria Capra
Journal:  Eur J Hum Genet       Date:  2003-03       Impact factor: 4.246

5.  Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

Authors: 
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

6.  Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity.

Authors:  F Shen; M Wu; J F Ross; D Miller; M Ratnam
Journal:  Biochemistry       Date:  1995-04-25       Impact factor: 3.162

7.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

Authors:  A E Czeizel; I Dudás
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

8.  Evidence that the hydrophobicity of isolated, in situ, and de novo-synthesized native human placental folate receptors is a function of glycosyl-phosphatidylinositol anchoring to membranes.

Authors:  R S Verma; S Gullapalli; A C Antony
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

9.  Expression of folate transporters in human placenta and implications for homocysteine metabolism.

Authors:  N Solanky; A Requena Jimenez; S W D'Souza; C P Sibley; J D Glazier
Journal:  Placenta       Date:  2009-12-28       Impact factor: 3.481

Review 10.  A comprehensive review of genetic association studies.

Authors:  Joel N Hirschhorn; Kirk Lohmueller; Edward Byrne; Kurt Hirschhorn
Journal:  Genet Med       Date:  2002 Mar-Apr       Impact factor: 8.822

View more
  17 in total

1.  Concept mapping One-Carbon Metabolism to model future ontologies for nutrient-gene-phenotype interactions.

Authors:  A C Joslin; R Green; J B German; M C Lange
Journal:  Genes Nutr       Date:  2014-08-05       Impact factor: 5.523

Review 2.  Finding the genetic mechanisms of folate deficiency and neural tube defects-Leaving no stone unturned.

Authors:  Kit Sing Au; Tina O Findley; Hope Northrup
Journal:  Am J Med Genet A       Date:  2017-09-25       Impact factor: 2.802

3.  Mutations in folate transporter genes and risk for human myelomeningocele.

Authors:  Tina O Findley; Joy C Tenpenny; Michelle R O'Byrne; Alanna C Morrison; James E Hixson; Hope Northrup; Kit Sing Au
Journal:  Am J Med Genet A       Date:  2017-09-26       Impact factor: 2.802

4.  Diet Alters Micronutrient Pathways in the Gut and Placenta that Regulate Fetal Growth and Development in Pregnant Mice.

Authors:  Elia Palladino; Tim Van Mieghem; Kristin L Connor
Journal:  Reprod Sci       Date:  2020-09-04       Impact factor: 3.060

5.  Evaluation of proton-coupled folate transporter (SLC46A1) polymorphisms as risk factors for neural tube defects and oral clefts.

Authors:  Julia E VanderMeer; Tonia C Carter; Faith Pangilinan; Adam Mitchell; Emma Kurnat-Thoma; Peadar N Kirke; James F Troendle; Anne M Molloy; Ronald G Munger; Marcia L Feldkamp; Maria A Mansilla; James L Mills; Jeff C Murray; Lawrence C Brody
Journal:  Am J Med Genet A       Date:  2016-01-20       Impact factor: 2.802

6.  Folate receptor 1 is necessary for neural plate cell apical constriction during Xenopus neural tube formation.

Authors:  Olga A Balashova; Olesya Visina; Laura N Borodinsky
Journal:  Development       Date:  2017-03-02       Impact factor: 6.868

Review 7.  Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease.

Authors:  Richard A Awad
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

8.  Polymorphisms in maternal folate pathway genes interact with arsenic in drinking water to influence risk of myelomeningocele.

Authors:  Maitreyi Mazumdar; Linda Valeri; Ema G Rodrigues; Md Omar Sharif Ibne Hasan; Rezina Hamid; Ligi Paul; Jacob Selhub; Fareesa Silva; Md Golam Mostofa; Quazi Quamruzzaman; Mahmuder Rahman; David C Christiani
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-08-06

Review 9.  Folate action in nervous system development and disease.

Authors:  Olga A Balashova; Olesya Visina; Laura N Borodinsky
Journal:  Dev Neurobiol       Date:  2018-02-06       Impact factor: 3.964

10.  Cerebral folate receptor autoantibodies in autism spectrum disorder.

Authors:  R E Frye; J M Sequeira; E V Quadros; S J James; D A Rossignol
Journal:  Mol Psychiatry       Date:  2012-01-10       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.